The FDA’s new framework for the use of digital health technologies will engage stakeholders to provide more guidelines for the industry.
A new framework from the US Food and Drug Administration includes plans to harmonize guidelines between departments to encourage the use of digital health technologies (DHT) in drug development.
Under the framework, the agency will host workshops with key stakeholders and develop internal processes for DHT evaluation and drug development
Mirvie launched Encompass, a blood test to help identify women over age 35 who are at moderate risk for preeclampsia, and will conduct additional studies to support reimbursements from payers.
Despite regional unrest, it is business as usual for medtech innovators and investors in Israel as evidenced by continued high-value M&A of locally developed technologies. Irit Yaniv, co-chair of the medtech session at the upcoming BioMed Israel 2025, explained the unique dynamics of Israeli medtech innovation.
Communication with patients has become a particularly crucial factor for investors, payers, and other healthcare decision-makers in a hostile market environment.
